Condition

Central Diabetes Insipidus

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 8 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials8

Recruiting2

Common interventions15

Lead sponsors shown5

Clinical trials

8 shown

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy ControlsNCT06808516 · 2025-07-01

RECRUITING

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsNCT06789705 · 2025-01-27

RECRUITING

Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in ChildrenNCT06604975 · 2025-03-01

NOT_YET_RECRUITING

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)NCT05319301 · 2022-04-01

COMPLETED

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)NCT04897802 · 2021-09-13

COMPLETED

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)NCT04902235 · 2021-07-06

COMPLETED

Seoul National University Pituitary Disease Cohort StudyNCT03474601 · 2015-03-15

UNKNOWN

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).NCT01280188 · 2011-01-01

COMPLETED

Common interventions

Control: Placebo administrationDRUG2 Desmopressin intranasalDRUG1 Desmopressin Oral MeltDRUG1 Dynamic hormone study and Magnetic resonance imagingOTHER1 Experimental: CRH administrationDRUG1 Experimental: GLP1-RA (exenatide) administrationDRUG1 IRMPROCEDURE1 MDMADRUG1 Measure of arginine-stimulated copeptinPROCEDURE1 Measure of Basal Copeptin levelPROCEDURE1 MelatoninDIETARY_SUPPLEMENT1 Oxytocin nasal sprayDRUG1 PlaceboDRUG1 PlaceboOTHER1 Water reduction at homeBEHAVIORAL1

Leading sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 3 University Hospital, Basel, Switzerland 2 Assistance Publique Hopitaux De Marseille 1 Ferring Pharmaceuticals 1 Seoul National University Hospital 1

Trial status mix

COMPLETED4

RECRUITING2

NOT_YET_RECRUITING1

UNKNOWN1

Phase mix

NA3

PHASE42

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.